We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
- Authors
Layton, D; Heeley, E; Hughes, K; Shakir, S A W
- Abstract
Rofecoxib and meloxicam are classified as cyclo-oxygenase (COX)-2 selective inhibitors. The Drug Safety Research Unit (DSRU) monitored the post-marketing safety of these drugs in England using the non-interventional observational cohort technique of prescription-event monitoring (PEM).
- Publication
Rheumatology (Oxford, England), 2003, Vol 42, Issue 11, p1342
- ISSN
1462-0324
- Publication type
Journal Article
- DOI
10.1093/rheumatology/keg379